Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Jun. 8];3:S2. Available from: https://skin.dermsquared.com/skin/article/view/729